Zymeworks (ZYME) Operating Expenses (2021 - 2026)

Zymeworks (ZYME) has 6 years of Operating Expenses data on file, last reported at $49.5 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 6.06% year-over-year to $49.5 million; the trailing twelve-month figure through Mar 2026 stood at $195.3 million (down 10.53% YoY), and the FY2025 full-year result was $198.5 million, down 6.98% from the prior year.
• Operating Expenses improved to $49.5 million in Q1 2026, from $46.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $83.1 million in Q4 2022 to a low of $40.3 million in Q4 2023.
• A 5-year average of $56.3 million and a median of $52.7 million in 2025 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 36.86% in 2022 and plunged 51.45% in 2023, its largest moves.
• Tracing ZYME's Operating Expenses over 5 years: stood at $83.1 million in 2022, then sank by 51.45% to $40.3 million in 2023, then jumped by 31.98% to $53.2 million in 2024, then slipped by 12.36% to $46.7 million in 2025, then increased by 6.13% to $49.5 million in 2026.
• Business Quant data shows ZYME's Operating Expenses at $49.5 million in Q1 2026, $46.7 million in Q4 2025, and $49.7 million in Q3 2025.